DrugUse-v3.2(2017EN): verschil tussen versies

Uit Zorginformatiebouwstenen
Ga naar: navigatie, zoeken
(Copy of)
 
(Een tussenliggende versie door dezelfde gebruiker niet weergegeven)
Regel 1: Regel 1:
−
==General information==
+
<!-- Hieronder wordt een transclude page aangeroepen -->
−
Name: '''nl.zorg.DrugUse''' [[Bestand:NL.png|link=DrugsGebruik-v3.2(2017NL)]]<BR>
+
{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.7.4(EN)|1|DrugUse-v3.2(2017EN)}}
−
Version: '''3.2''' <br>
+
<!-- Tot hier de transclude page -->
−
HCIM Status:Final<br>
+
==General information<!--hdGeneralInformation-->==
−
Release: '''2017''' <br>
+
Name<!--hdName-->: '''nl.zorg.DrugUse''' [[Bestand:NL.png|link=DrugsGebruik-v3.2(2017NL)]]<BR>
−
Release status: Published<br>
+
Version<!--hdVersion-->: '''3.2''' <br>
−
Release date: 31-12-2017
+
HCIM Status<!--hdStatus-->:Final<br>
 +
Release<!--hdPublication-->: '''2017''' <br>
 +
Release status<!--hdPublicationStatus-->: Published<br>
 +
Release date<!--hdPublicationDate-->: 31-12-2017
 
-----
 
-----
−
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div>
+
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2017(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2017(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div>
  
 
==Metadata==
 
==Metadata==
Regel 61: Regel 64:
 
==Revision History==
 
==Revision History==
 
<div class="mw-collapsible mw-collapsed">
 
<div class="mw-collapsible mw-collapsed">
−
''Only available in Dutch''
+
''Only available in Dutch<!--noTranslation-->''
  
 
<u>Publicatieversie 1.0</u> (15-02-2013)
 
<u>Publicatieversie 1.0</u> (15-02-2013)
Regel 196: Regel 199:
 
==Information Model==
 
==Information Model==
 
<BR>
 
<BR>
−
<imagemap> Bestand:DrugUse-v3.2Model(EN).png | center  
+
<imagemap> Bestand:DrugUse-v3.2Model(2017EN).png | center  
−
rect 515 239 660 309 [[#11349]]
+
rect 525 247 670 317 [[#11349]]
−
rect 692 249 869 299 [[#RouteOfAdministrationCodelist]]
+
rect 702 257 879 307 [[#RouteOfAdministrationCodelist]]
−
rect 693 149 870 199 [[#DrugUseStatusCodelist]]
+
rect 703 157 880 207 [[#DrugUseStatusCodelist]]
−
rect 347 358 437 428 [[#11356]]
+
rect 357 366 447 436 [[#11356]]
−
rect 331 233 455 303 [[#11342]]
+
rect 341 241 465 311 [[#11342]]
−
rect 692 48 901 98 [[#TypeOfDrugOrMedicationCodelist]]
+
rect 702 56 911 106 [[#TypeOfDrugOrMedicationCodelist]]
−
rect 515 137 660 207 [[#11347]]
+
rect 525 145 670 215 [[#11347]]
−
rect 515 41 660 111 [[#11354]]
+
rect 525 49 670 119 [[#11354]]
−
rect 166 306 260 376 [[#11335]]
+
rect 176 314 270 384 [[#11335]]
−
rect 166 208 260 278 [[#11352]]
+
rect 176 216 270 286 [[#11352]]
−
rect 330 105 454 186 [[#11336]]
+
rect 340 113 464 194 [[#11336]]
−
rect 166 110 260 180 [[#11333]]
+
rect 176 118 270 188 [[#11333]]
 
desc none
 
desc none
 
</imagemap>
 
</imagemap>
Regel 214: Regel 217:
 
{| border= "1"  width="1500px" style = "font-size: 9.5pt;  border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px"  
 
{| border= "1"  width="1500px" style = "font-size: 9.5pt;  border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px"  
 
|-style="background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; "
 
|-style="background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; "
−
|style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference
+
|style="width:30px;"|Type<!--imType-->||style="width:100px;"|Id<!--imId-->||colspan="6 " style="width:140px;"|Concept<!--imConcept-->||Card.<!--imCard-->||style="width: 600px;"|Definition<!--imDefinition-->||style="width:200px;"|DefinitionCode<!--imDefinitionCode-->||style="width:200px;"|Reference<!--imReference-->
 
|-style="vertical-align:top; background-color: #E3E3E3; "
 
|-style="vertical-align:top; background-color: #E3E3E3; "
 
|style = "text-align:center" |[[Bestand: block.png| 20px | link=]]
 
|style = "text-align:center" |[[Bestand: block.png| 20px | link=]]
Regel 272: Regel 275:
 
{|
 
{|
 
|-
 
|-
−
|<span Title="Codesystem: LOINC"> 48767-8 Annotation comment</span>
+
|<span title = "Codesystem: LOINC>[https://terminologie.nictiz.nl/art-decor/loinc?conceptId=48767-8 48767-8] Annotation comment</span>
 
|}
 
|}
 
|
 
|
Regel 298: Regel 301:
 
{|
 
{|
 
|-
 
|-
−
|<span Title="Codesystem: SNOMED CT"> 228366006 Finding related to drug misuse behaviour (finding)</span>
+
|<span title = "Codesystem: SNOMED CT>[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=228366006 228366006] Finding related to drug misuse behaviour (finding)</span>
 
|}
 
|}
 
|
 
|
Regel 315: Regel 318:
 
{|
 
{|
 
|-
 
|-
−
|<span Title="Codesystem: SNOMED CT"> 410675002 Route of administration</span>
+
|<span title = "Codesystem: SNOMED CT>[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=410675002 410675002] Route of administration</span>
 
|}
 
|}
 
|
 
|
Regel 323: Regel 326:
 
|}
 
|}
 
|}
 
|}
−
Columns Concept and DefinitionCode: hover over the values for more information<BR>
+
Columns Concept and DefinitionCode: hover over the values for more information<!--imHover--><BR>
−
For explanation of the symbols, please see the legend page [[Bestand:list2.png|link=Legend]]
+
For explanation of the symbols, please see the legend page<!--imLegend--> [[Bestand:list2.png|link=Legend<!--wikiLegend-->]]
  
 
==Example Instances==
 
==Example Instances==
−
''Only available in Dutch''
+
''Only available in Dutch<!--noTranslation-->''
  
 
{|class="wikitable" width="791px" style= "font-size: 9.5pt;"
 
{|class="wikitable" width="791px" style= "font-size: 9.5pt;"
Regel 371: Regel 374:
 
{| class="wikitable" width="60%"  
 
{| class="wikitable" width="60%"  
 
|-style='vertical-align:top; background-color: #E8D7BE;'
 
|-style='vertical-align:top; background-color: #E8D7BE;'
−
|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2
+
|Valueset OID<!--vsValuesetOID-->: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2
 +
|Binding<!--vsBindingTag-->:
 
|}
 
|}
 
{| class="wikitable"  width="60% "
 
{| class="wikitable"  width="60% "
 
|-style="background-color: #1F497D; color: white; font-weight: bold; "
 
|-style="background-color: #1F497D; color: white; font-weight: bold; "
−
|Conceptname
+
|Conceptname<!--vsConceptName-->
−
|Conceptcode
+
|Conceptcode<!--vsConceptCode-->
−
|Codesystem name||Codesystem OID
+
|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
−
|Description
+
|Description<!--vsDescription-->
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Misuses drugs (finding)
 
|Misuses drugs (finding)
−
|361055000
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=361055000 361055000]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 387: Regel 391:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Does not misuse drugs (finding)
 
|Does not misuse drugs (finding)
−
|228367002
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=228367002 228367002]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 393: Regel 397:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Has never misused drugs
 
|Has never misused drugs
−
|228368007
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=228368007 228368007]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 399: Regel 403:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Misused drugs in past (finding)
 
|Misused drugs in past (finding)
−
|44870007
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=44870007 44870007]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 410: Regel 414:
 
|anders
 
|anders
 
|}
 
|}
−
 
 
=== RouteOfAdministrationCodelist===
 
=== RouteOfAdministrationCodelist===
 
{| class="wikitable" width="60%"  
 
{| class="wikitable" width="60%"  
 
|-style='vertical-align:top; background-color: #E8D7BE;'
 
|-style='vertical-align:top; background-color: #E8D7BE;'
−
|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.3
+
|Valueset OID<!--vsValuesetOID-->: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.3
 +
|Binding<!--vsBindingTag-->:
 
|}
 
|}
 
{| class="wikitable"  width="60% "
 
{| class="wikitable"  width="60% "
 
|-style="background-color: #1F497D; color: white; font-weight: bold; "
 
|-style="background-color: #1F497D; color: white; font-weight: bold; "
−
|Conceptname
+
|Conceptname<!--vsConceptName-->
−
|Conceptcode
+
|Conceptcode<!--vsConceptCode-->
−
|Codesystem name||Codesystem OID
+
|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
−
|Description
+
|Description<!--vsDescription-->
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|ORAAL
 
|ORAAL
Regel 453: Regel 457:
 
|Anders
 
|Anders
 
|}
 
|}
−
 
 
=== TypeOfDrugOrMedicationCodelist===
 
=== TypeOfDrugOrMedicationCodelist===
 
{| class="wikitable" width="60%"  
 
{| class="wikitable" width="60%"  
 
|-style='vertical-align:top; background-color: #E8D7BE;'
 
|-style='vertical-align:top; background-color: #E8D7BE;'
−
|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1
+
|Valueset OID<!--vsValuesetOID-->: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1
 +
|Binding<!--vsBindingTag-->:
 
|}
 
|}
 
{| class="wikitable"  width="60% "
 
{| class="wikitable"  width="60% "
 
|-style="background-color: #1F497D; color: white; font-weight: bold; "
 
|-style="background-color: #1F497D; color: white; font-weight: bold; "
−
|Conceptname
+
|Conceptname<!--vsConceptName-->
−
|Conceptcode
+
|Conceptcode<!--vsConceptCode-->
−
|Codesystem name||Codesystem OID
+
|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
−
|Description
+
|Description<!--vsDescription-->
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Heroin (substance)
 
|Heroin (substance)
−
|387341002
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387341002 387341002]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 473: Regel 477:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Benzodiazepine (substance)
 
|Benzodiazepine (substance)
−
|372664007
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=372664007 372664007]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 479: Regel 483:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Methadone (substance)
 
|Methadone (substance)
−
|387286002
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387286002 387286002]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 485: Regel 489:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Hydroxybutyric acid (substance)
 
|Hydroxybutyric acid (substance)
−
|62821004
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=62821004 62821004]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 491: Regel 495:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Cocaine (substance)
 
|Cocaine (substance)
−
|387085005
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387085005 387085005]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 497: Regel 501:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Cocaine freebase (substance)
 
|Cocaine freebase (substance)
−
|229003004
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=229003004 229003004]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 503: Regel 507:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Methylenedioxymethamphetamine (substance)
 
|Methylenedioxymethamphetamine (substance)
−
|288459003
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=288459003 288459003]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 509: Regel 513:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Amphetamine (substance)
 
|Amphetamine (substance)
−
|703842006
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=703842006 703842006]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 515: Regel 519:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Cannabis (substance)
 
|Cannabis (substance)
−
|398705004
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=398705004 398705004]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 521: Regel 525:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Hallucinogenic mushrooms (substance)
 
|Hallucinogenic mushrooms (substance)
−
|229006007
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=229006007 229006007]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 527: Regel 531:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Lysergic acid diethylamide (substance)
 
|Lysergic acid diethylamide (substance)
−
|15698006
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=15698006 15698006]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 533: Regel 537:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Ketamine (substance)
 
|Ketamine (substance)
−
|373464007
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=373464007 373464007]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 539: Regel 543:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Phencyclidine (substance)
 
|Phencyclidine (substance)
−
|9721008
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=9721008 9721008]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 545: Regel 549:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Methamphetamine (substance)
 
|Methamphetamine (substance)
−
|387499002
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387499002 387499002]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 551: Regel 555:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Anabolic steroid (substance)
 
|Anabolic steroid (substance)
−
|111151007
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=111151007 111151007]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 557: Regel 561:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Laxative (substance)
 
|Laxative (substance)
−
|372800002
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=372800002 372800002]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 563: Regel 567:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Buprenorphine (substance)
 
|Buprenorphine (substance)
−
|387173000
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387173000 387173000]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 569: Regel 573:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Fentanyl (substance)
 
|Fentanyl (substance)
−
|373492002
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=373492002 373492002]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 575: Regel 579:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Barbiturate (substance)
 
|Barbiturate (substance)
−
|372798009
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=372798009 372798009]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 587: Regel 591:
 
|}
 
|}
  
−
 
+
==This information model in other releases<!--ftOtherReleases-->==
−
==This information model in other releases==
+
<!-- Hieronder wordt een transclude page aangeroepen -->
−
<ul>
+
{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.7.4(EN)|2|2017}}
−
<li>[[DrugUse-v1.2.2(2015EN) | Release 2015, (Version 1.2.2)]]</li>
+
<!-- Tot hier de transclude page -->
−
<li>[[DrugUse-v3.0(2016EN) | Release 2016, (Version 3.0)]]</li>
+
==Information model references<!--ftReferences-->==
−
</ul>
+
====This information model refers to<!--ftRefersTo-->====
−
==More on this information model==
+
:--
 +
====This information model is used in<!--ftReferredBy-->====
 +
:--
 +
==Technical specifications in HL7v3 CDA and HL7 FHIR<!--ftHeader-->==
 
To exchange information based on health and care information models, additional, more technical specifications are required.<BR>
 
To exchange information based on health and care information models, additional, more technical specifications are required.<BR>
−
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
+
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:<!--ftReferenceIntro-->
 
<ul>
 
<ul>
−
<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2017bbr-?id=2.16.840.1.113883.2.4.3.11.60.7.4.2.7.4&effectiveDate=2017-12-31T00:00:00&language=en-US&scenariotree=false [[File:artdecor.jpg|16px|link=]]]</li>
+
<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment<!--ftArtDecorReference--> [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2017bbr-?id=2.16.840.1.113883.2.4.3.11.60.7.4.2.7.4&effectiveDate=2017-12-31T00:00:00&language=en-US&scenariotree=false [[File:artdecor.jpg|16px|link=]]]</li>
−
<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR [https://simplifier.net/NictizSTU3/~resources?text=zib&category=Profile [[File:fhir.png|link=]]]</li>
+
<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR<!--ftSimplifierReference--> {{SimplefierLinks|2017}}</li>
 
</ul>
 
</ul>
−
This information model is also available as [[Media:nl.zorg.DrugUse-v3.2(2017EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.DrugUse-v3.2(2017EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]
+
==Downloads<!--ftDownloadTitle-->==
−
==About this information==
+
This information model is also available as [[Media:nl.zorg.DrugUse-v3.2(2017EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.DrugUse-v3.2(2017EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]<!--ftDownloads-->
−
The information in this wikipage is based on Release 2017 <BR>
+
==About this information<!--ftHeader2-->==
−
Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]]<BR>
+
The information in this wikipage is based on<!--ftInfoBase--> Release 2017 <BR>
−
This page is generated on 24/01/2018 15:57:16 <BR>
+
Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR>
 +
This page is generated on 21/12/2018 14:09:28 with ZibExtraction v. 3.0.6929.24609<!--ftDate--> <BR>
 
-----
 
-----
−
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div>
+
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2017(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2017(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div>

Huidige versie van 24 dec 2018 om 11:03


Attention!! This is not the most recent version of this information model. You can find the most recent version ''here''.

General information

Name: nl.zorg.DrugUse NL.png
Version: 3.2
HCIM Status:Final
Release: 2017
Release status: Published
Release date: 31-12-2017

Back 16.png Back to HCIM list

Metadata

DCM::CoderList Kerngroep Registratie aan de Bron
DCM::ContactInformation.Address *
DCM::ContactInformation.Name *
DCM::ContactInformation.Telecom *
DCM::ContentAuthorList Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron
DCM::CreationDate 5-7-2012
DCM::DeprecatedDate
DCM::DescriptionLanguage nl
DCM::EndorsingAuthority.Address
DCM::EndorsingAuthority.Name PM
DCM::EndorsingAuthority.Telecom
DCM::Id 2.16.840.1.113883.2.4.3.11.60.40.3.7.4
DCM::KeywordList drugsgebruik, verdovende middelen, middelen gebruik, drugs
DCM::LifecycleStatus Final
DCM::ModelerList Kerngroep Registratie aan de Bron
DCM::Name nl.zorg.DrugsGebruik
DCM::PublicationDate 31-12-2017
DCM::PublicationStatus Published
DCM::ReviewerList Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron
DCM::RevisionDate 31-12-2017
DCM::Superseeds nl.zorg.DrugsGebruik-v3.1
DCM::Version 3.2
HCIM::PublicationLanguage EN

Revision History

Only available in Dutch

Publicatieversie 1.0 (15-02-2013)

Publicatieversie 1.1 (01-07-2013)

Publicatieversie 1.2 (01-04-2015)

ZIB-138 Aanpassingen in SNOMED CT codes en omschrijvingen voor codelijst DrugsGebruikStatusCodelijst n.a.v. review terminologie expert.
ZIB-139 Aanpassingen in SNOMED CT codes en omschrijvingen voor codelijst DrugsOfGeneesmiddelSoortCodelijst n.a.v. review terminologie expert.
ZIB-158 Cardinaliteit SoortMiddel aanpassen in bouwsteen OverdrachtDrugsgebruik
ZIB-161 Het concept Hoeveelheid van bouwsteen OverdrachtDrugsgebruik.
ZIB-167 Bevindingen Concept inrichting Intoxicatie Roken/ Alcohol en Drugs in EZIS.NET
ZIB-224 In de klinische bouwsteen OverdrachtDrugsgebruik, concept SoortMiddel komt tagged value DrugsOfGeneesmiddelSoortCodelijst niet overeen met naam gekoppelde valueset DrugsOfGeneesmiddelSoort.
ZIB-225 In de klinische bouwsteen OverdrachtDrugsgebruik, concept ToedieningsWeg komt tagged value ToedieningsWegCodelijst niet overeen met naam gekoppelde valueset.
ZIB-308 Prefix Overdracht weggehaald bij de generieke bouwstenen
ZIB-312 aanpassing paragraaf 'Concept'
ZIB-313 Aanpassen paragraaf 'Purpose'
ZIB-316 Paragraaf 'Evidence base' wijzigen
ZIB-319 Wijzing paragraaf Constraint

Incl. algemene wijzigingsverzoeken:

ZIB-94 Aanpassen tekst van Disclaimer, Terms of Use & Copyrights
ZIB-154 Consequenties opsplitsing Medicatie bouwstenen voor overige bouwstenen.
ZIB-200 Naamgeving SNOMED CT in tagged values klinische bouwstenen gelijk getrokken.
ZIB-201 Naamgeving OID: in tagged value notes van klinische bouwstenen gelijk getrokken.
ZIB-309 EOI aangepast
ZIB-324 Codelijsten Name en Description beginnen met een Hoofdletter
ZIB-326 Tekstuele aanpassingen conform de kwaliteitsreview kerngroep 2015

Publicatieversie 1.2.1 (22-05-2015)

ZIB-388 De ToedieningswegCodelijst heeft geen "OID: " aanduiding in de onderliggende codelijst.

Publicatieversie 1.2.2 (16-07-2015)

ZIB-418 Vervallen SNOMED CT code in DrugsOfGeneesmiddelSoortCodelijst

Publicatieversie 3.0 (01-05-2016)

ZIB-453 Wijziging naamgeving ZIB's en logo's door andere opzet van beheer

Publicatieversie 3.1 (04-09-2017)

ZIB-475 Terminologiekoppeling Drugsgebruik
ZIB-488 niet compleet
ZIB-505 Geen informatie
ZIB-512 Hoe houd je verschillende adresgegevens uit elkaar?
ZIB-564 Aanpassing/harmonisatie Engelse conceptnamen

Publicatieversie 3.2 (31-12-2017)

ZIB-555 Uitbreiding codelijst van ZIB DrugsGebruik

.

Concept

Drugs (or: narcotics, amphetamines, intoxicants, highs, hallucinogenics, illegal substances or dope) is a collective term for drugs and chemical substances with a more or less ‘drugging' (anesthetic, boosting and/or hallucinogenic) effect and which can lead to addiction. Drug [Online] Available at: nl.Wikipedia.org/wiki/drug [Accessed: 11 February 2015].

This information model describes the information asked of the patient about their drug use.

Purpose

Documenting and sharing registration of the drug use, as described in the concept.

Evidence Base

Though this information model can also be used to abuse (the patient’s own) medication, the project group eventually decided to focus on information on drug use, as described in the concept.
Seeing as there is a large variety of ways to record the amount of drugs used, we decided that this part is to be entered as free text.

Information Model


#11349#RouteOfAdministrationCodelist#DrugUseStatusCodelist#11356#11342#TypeOfDrugOrMedicationCodelist#11347#11354#11335#11352#11336#11333DrugUse-v3.2Model(2017EN).png


Type Id Concept Card. Definition DefinitionCode Reference
Block.png NL-CM:7.4.1 Arrowdown.pngDrugUse Root concept of the DrugUse information model. This concept contains all data elements of the DrugUse information model.
Folder.png NL-CM:7.4.5 Arrowdown.pngObservationOfUse 0..1 Container for ObservationOfUse. This container contains all data elements of the ObservationOfUse container.
TS.png NL-CM:7.4.6 Arrowright.pngStartDate 0..1 The date on which the patient started using.
TS.png NL-CM:7.4.7 Arrowright.pngStopDate 0..1 The date on which the patient quit using
ST.png NL-CM:7.4.8 Arrowright.pngAmount 0..1 The number of units (pills, joints, shots etc.) per day, week, month or year or the frequency of use.
ST.png NL-CM:7.4.9 Arrowright.pngComment 0..1 Relevant comments on the drug use.
48767-8 Annotation comment
CD.png NL-CM:7.4.2 Arrowright.pngDrugOrMedicationType 0..1 Type of drug used by the patient.
List2.png TypeOfDrugOrMedicationCodelist
CD.png NL-CM:7.4.3 Arrowright.pngDrugUseStatus 1 Indication stating whether there was any drug use in the past or present.
228366006 Finding related to drug misuse behaviour (finding)
List2.png DrugUseStatusCodelist
CD.png NL-CM:7.4.4 Arrowright.pngRouteOfAdministration 0..* The way the drugs are used.
410675002 Route of administration
List2.png RouteOfAdministrationCodelist

Columns Concept and DefinitionCode: hover over the values for more information
For explanation of the symbols, please see the legend page List2.png

Example Instances

Only available in Dutch

DrugsOfGeneesmiddel Drugs Gebruik Status Start datum Stop datum Toedieningsweg Hoeveelheid Toelichting
XTC misbruikt drugs 1985 oraal 2x per maand Op feestjes en in uitgaanscircuit. Vroeger wat meer dan tegenwoordig.
DrugsOfGeneesmiddel Drugs Gebruik Status Start datum Stop datum Toedieningsweg Hoeveelheid Toelichting
Heroïne heeft in het verleden drugs gebruikt 1970 1985 intraveneus 3x per week

Instructions

The 'DrugOrMedicationTypeCodelist is extensible. If the drug in question is not on the codelist, the list can be extended with a code from the SNOMED CT hierarchy 'Substance; <105590001' or if necessary from the hierarchy 'Pharmaceutical/biologic product; < 373873005'.

Valuesets

DrugUseStatusCodelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2 Binding:
Conceptname Conceptcode Codesystem name Codesystem OID Description
Misuses drugs (finding) 361055000 SNOMED CT 2.16.840.1.113883.6.96 gebruikt drugs
Does not misuse drugs (finding) 228367002 SNOMED CT 2.16.840.1.113883.6.96 gebruikt geen drugs
Has never misused drugs 228368007 SNOMED CT 2.16.840.1.113883.6.96 heeft nooit drugs gebruikt
Misused drugs in past (finding) 44870007 SNOMED CT 2.16.840.1.113883.6.96 heeft in het verleden drugs gebruikt
Other OTH NullFlavor 2.16.840.1.113883.5.1008 anders

RouteOfAdministrationCodelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.3 Binding:
Conceptname Conceptcode Codesystem name Codesystem OID Description
ORAAL 9 G-Standaard Toedieningswegen 2.16.840.1.113883.2.4.4.9 oraal
NASAAL 6 G-Standaard Toedieningswegen 2.16.840.1.113883.2.4.4.9 nasaal (snuiven)
INHALATIE 62 G-Standaard Toedieningswegen 2.16.840.1.113883.2.4.4.9 Inhalatie (roken)
INTRAVENEUS 5 G-Standaard Toedieningswegen 2.16.840.1.113883.2.4.4.9 Intraveneus (spuiten)
Other OTH NullFlavor 2.16.840.1.113883.5.1008 Anders

TypeOfDrugOrMedicationCodelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1 Binding:
Conceptname Conceptcode Codesystem name Codesystem OID Description
Heroin (substance) 387341002 SNOMED CT 2.16.840.1.113883.6.96 Heroïne
Benzodiazepine (substance) 372664007 SNOMED CT 2.16.840.1.113883.6.96 Benzodiazepine
Methadone (substance) 387286002 SNOMED CT 2.16.840.1.113883.6.96 Methadon
Hydroxybutyric acid (substance) 62821004 SNOMED CT 2.16.840.1.113883.6.96 GHB
Cocaine (substance) 387085005 SNOMED CT 2.16.840.1.113883.6.96 Cocaïne
Cocaine freebase (substance) 229003004 SNOMED CT 2.16.840.1.113883.6.96 Crack, base coke
Methylenedioxymethamphetamine (substance) 288459003 SNOMED CT 2.16.840.1.113883.6.96 MDMA
Amphetamine (substance) 703842006 SNOMED CT 2.16.840.1.113883.6.96 Amfetamine, speed
Cannabis (substance) 398705004 SNOMED CT 2.16.840.1.113883.6.96 Cannabis, wiet marihuana, hasj
Hallucinogenic mushrooms (substance) 229006007 SNOMED CT 2.16.840.1.113883.6.96 Paddos
Lysergic acid diethylamide (substance) 15698006 SNOMED CT 2.16.840.1.113883.6.96 LSD
Ketamine (substance) 373464007 SNOMED CT 2.16.840.1.113883.6.96 Ketamine
Phencyclidine (substance) 9721008 SNOMED CT 2.16.840.1.113883.6.96 PCP
Methamphetamine (substance) 387499002 SNOMED CT 2.16.840.1.113883.6.96 Crystal meth, methamfetamine
Anabolic steroid (substance) 111151007 SNOMED CT 2.16.840.1.113883.6.96 Anabole steroïde
Laxative (substance) 372800002 SNOMED CT 2.16.840.1.113883.6.96 Laxans
Buprenorphine (substance) 387173000 SNOMED CT 2.16.840.1.113883.6.96 Buprenorfine
Fentanyl (substance) 373492002 SNOMED CT 2.16.840.1.113883.6.96 Fentanyl
Barbiturate (substance) 372798009 SNOMED CT 2.16.840.1.113883.6.96 Barbituraat
Other OTH NullFlavor 2.16.840.1.113883.5.1008 Anders

This information model in other releases

Information model references

This information model refers to

--

This information model is used in

--

Technical specifications in HL7v3 CDA and HL7 FHIR

To exchange information based on health and care information models, additional, more technical specifications are required.
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:

  • HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment Artdecor.jpg
  • HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR Fhir.png

Downloads

This information model is also available as pdf file PDF.png or as spreadsheet Xlsx.png

About this information

The information in this wikipage is based on Release 2017
Conditions for use are located on the mainpage List2.png
This page is generated on 21/12/2018 14:09:28 with ZibExtraction v. 3.0.6929.24609

Back 16.png Back to HCIM list
Overgenomen van "https://zibs.nl/index.php?title=DrugUse-v3.2(2017EN)&oldid=15828"